Variant report

Variant	esv3423559
Chromosome Location	chr17:18282155-18287887
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:61)
CpG islands
(count:428)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:61 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:18283094-18283294	K562	blood:	n/a	n/a
2	BHLHE40	chr17:18284936-18285074	K562	blood:	n/a	n/a
3	BHLHE40	chr17:18282904-18283115	K562	blood:	n/a	n/a
4	CEBPB	chr17:18282090-18282251	IMR90	lung:	n/a	n/a
5	CHD2	chr17:18285011-18285049	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTCF	chr17:18286594-18286698	GM10248	blood:	n/a	n/a
7	CTCF	chr17:18286390-18286454	GM12878	blood:	n/a	n/a
8	CTCF	chr17:18286260-18286410	HMEC	breast:	n/a	n/a
9	CTCF	chr17:18286617-18286690	GM12878	blood:	n/a	n/a
10	CTCF	chr17:18286554-18286729	GM12891	blood:	n/a	n/a
11	CTCF	chr17:18282940-18283090	NB4	blood:	n/a	n/a
12	CTCF	chr17:18286364-18286421	Pancreas_OC	pancreas:	n/a	n/a
13	CTCF	chr17:18284761-18284780	GM10248	blood:	n/a	n/a
14	CTCF	chr17:18286605-18286698	GM12892	blood:	n/a	n/a
15	CTCF	chr17:18286351-18286459	GM12891	blood:	n/a	n/a
16	CTCF	chr17:18283020-18283170	A549	lung:	n/a	n/a
17	CTCF	chr17:18286408-18286440	Fibrobl	skin:	n/a	n/a
18	CTCF	chr17:18282460-18282610	NHEK	skin:	n/a	n/a
19	CTCF	chr17:18282920-18283070	HBMEC	blood vessel:	n/a	n/a
20	CTCF	chr17:18286586-18286682	Spleen_OC	spleen:	n/a	n/a
21	CTCF	chr17:18284300-18284450	HepG2	liver:	n/a	chr17:18284389-18284410 chr17:18284395-18284411 chr17:18284397-18284407 chr17:18284394-18284412 chr17:18284396-18284409
22	CTCF	chr17:18284380-18284435	Hela-S3	cervix:	n/a	chr17:18284389-18284410 chr17:18284395-18284411 chr17:18284397-18284407 chr17:18284394-18284412 chr17:18284396-18284409
23	CTCF	chr17:18282960-18283110	MCF-7	breast:	n/a	n/a
24	CTCF	chr17:18282960-18283110	SK-N-SH_RA	brain:	n/a	n/a
25	CTCF	chr17:18283000-18283150	HEK293	kidney:	n/a	n/a
26	CTCF	chr17:18283000-18283150	HMEC	breast:	n/a	n/a
27	CTCF	chr17:18282960-18283110	GM12864	blood:	n/a	n/a
28	CTCF	chr17:18286400-18286550	GM12864	blood:	n/a	n/a
29	E2F6	chr17:18286289-18286765	H1-hESC	embryonic stem cell:	n/a	n/a
30	E2F6	chr17:18286291-18286783	H1-hESC	embryonic stem cell:	n/a	n/a
31	EBF1	chr17:18284235-18284474	GM12878	blood:	n/a	n/a
32	FOS	chr17:18282045-18282182	MCF10A-Er-Src	breast:	n/a	n/a
33	MAX	chr17:18282904-18283161	K562	blood:	n/a	n/a
34	MAX	chr17:18286191-18286617	ECC-1	luminal epithelium:	n/a	chr17:18286522-18286532
35	MAX	chr17:18286204-18286665	ECC-1	luminal epithelium:	n/a	chr17:18286522-18286532
36	MAX	chr17:18286314-18286857	H1-hESC	embryonic stem cell:	n/a	chr17:18286522-18286532
37	MAX	chr17:18286303-18286852	H1-hESC	embryonic stem cell:	n/a	chr17:18286522-18286532
38	MYC	chr17:18285676-18285738	HUVEC	blood vessel:	n/a	n/a
39	MYC	chr17:18282055-18282255	MCF10A-Er-Src	breast:	n/a	n/a
40	MYC	chr17:18282763-18282764	MCF-7	breast:	n/a	n/a
41	MYC	chr17:18282782-18282930	MCF-7	breast:	n/a	n/a
42	MYC	chr17:18282767-18282781	MCF-7	breast:	n/a	n/a
43	POLR2A	chr17:18282540-18282785	MCF-7	breast:	n/a	n/a
44	POLR2A	chr17:18286531-18286712	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr17:18282554-18282999	MCF-7	breast:	n/a	n/a
46	POLR2A	chr17:18282869-18282974	MCF-7	breast:	n/a	n/a
47	RCOR1	chr17:18283191-18283450	K562	blood:	n/a	n/a
48	RCOR1	chr17:18285142-18285267	K562	blood:	n/a	n/a
49	RCOR1	chr17:18283012-18283446	K562	blood:	n/a	n/a
50	RCOR1	chr17:18285024-18285298	K562	blood:	n/a	n/a

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:18285810-18285860	AoSMC	blood vessel:	n/a
2	chr17:18285810-18285860	AoSMC	blood vessel:	n/a
3	chr17:18286412-18286462	NHDF-neo	bronchial:	n/a
4	chr17:18285838-18285888	AoSMC	blood vessel:	n/a
5	chr17:18286412-18286462	HRCEpiC	kidney:	n/a
6	chr17:18286644-18286694	SK-N-MC	brain:	n/a
7	chr17:18285838-18285888	HEEpiC	esophagus:	n/a
8	chr17:18285810-18285860	HNPCEpiC	eye:	n/a
9	chr17:18285838-18285888	HUVEC	blood vessel:	n/a
10	chr17:18283678-18283728	GM19239	blood:	n/a
11	chr17:18285810-18285860	ovcar-3	ovarian:	n/a
12	chr17:18285838-18285888	A549	lung:	n/a
13	chr17:18286644-18286694	MCF10A-Er-Src	breast:	n/a
14	chr17:18286412-18286462	CMK	blood:	n/a
15	chr17:18285838-18285888	HPAEpiC	pulmonary alveolar:	n/a
16	chr17:18286412-18286462	AG04449	skin:	fetal
17	chr17:18286412-18286462	H1-hESC	embryonic stem cell:	embryo
18	chr17:18286644-18286694	U87	brain:	n/a
19	chr17:18286412-18286462	SK-N-SH_RA	brain:	n/a
20	chr17:18287814-18287864	A549	lung:	n/a
21	chr17:18283678-18283728	HRE	kidney:	n/a
22	chr17:18283586-18283636	NT2-D1	testis:	n/a
23	chr17:18286412-18286462	T-47D	breast:	n/a
24	chr17:18285838-18285888	PANC-1	pancreas:	n/a
25	chr17:18287814-18287864	CMK	blood:	n/a
26	chr17:18285810-18285860	GM12878	blood:	n/a
27	chr17:18285838-18285888	U87	brain:	n/a
28	chr17:18286644-18286694	HCF	heart:	n/a
29	chr17:18283586-18283636	GM12878	blood:	n/a
30	chr17:18286644-18286694	HCT-116	colon:	n/a
31	chr17:18283678-18283728	HAEpiC	amniotic membrane:	n/a
32	chr17:18287814-18287864	MCF10A-Er-Src	breast:	n/a
33	chr17:18283586-18283636	MCF10A-Er-Src	breast:	n/a
34	chr17:18283678-18283728	ECC-1	luminal epithelium:	n/a
35	chr17:18287814-18287864	AG04449	skin:	fetal
36	chr17:18283678-18283728	MCF10A-Er-Src	breast:	n/a
37	chr17:18283586-18283636	HCM	heart:	n/a
38	chr17:18283586-18283636	IMR90	lung:	fetal
39	chr17:18287814-18287864	ovcar-3	ovarian:	n/a
40	chr17:18285838-18285888	MCF10A-Er-Src	breast:	n/a
41	chr17:18285838-18285888	NB4	blood:	n/a
42	chr17:18286644-18286694	RPTEC	kidney:	n/a
43	chr17:18285838-18285888	SK-N-SH	brain:	n/a
44	chr17:18283586-18283636	HMEC	breast:	n/a
45	chr17:18283678-18283728	A549	lung:	n/a
46	chr17:18287814-18287864	NH-A	brain:	n/a
47	chr17:18283586-18283636	GM06990	blood:	n/a
48	chr17:18287814-18287864	HRPEpiC	eye:	n/a
49	chr17:18285838-18285888	GM12892	blood:	n/a
50	chr17:18286644-18286694	PFSK-1	brain:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:18271062..18274039-chr17:18283398..18285584,2	MCF-7	breast:
2	chr17:18278481..18280376-chr17:18284493..18286607,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000267441	TF binding region
EVPLL	TF binding region
ENSG00000267441	CpG island
EVPLL	CpG island

Extended variants
information (count: 225 )
Associated
traits (count: 163 )

Variant overlapped rSNPs/rCNVs (count:225 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1985778	chr17:18282157-18282158	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs3890473	chr17:18282171-18282172	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs56793258	chr17:18282189-18282190	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs555389568	chr17:18282249-18282250	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs149882236	chr17:18282342-18282343	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs113939344	chr17:18282343-18282344	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
7	rs373368755	chr17:18282410-18282411	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs557542573	chr17:18282451-18282452	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs140882909	chr17:18282477-18282478	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs546442714	chr17:18282642-18282643	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs568763050	chr17:18282665-18282666	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs3764406	chr17:18282676-18282677	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs143307365	chr17:18282682-18282683	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs541854511	chr17:18282691-18282692	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs561784397	chr17:18282692-18282693	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs146844467	chr17:18282694-18282695	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs544299515	chr17:18282792-18282793	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs563908034	chr17:18282843-18282844	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs111690746	chr17:18282903-18282904	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs77513611	chr17:18282933-18282934	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs112624894	chr17:18282953-18282954	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs140688903	chr17:18282962-18282963	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs529105526	chr17:18282980-18282981	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs529230765	chr17:18282991-18282992	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs548960010	chr17:18283020-18283021	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs143794599	chr17:18283024-18283025	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs188749957	chr17:18283029-18283030	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs191649189	chr17:18283093-18283094	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs571353200	chr17:18283104-18283105	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs377763266	chr17:18283105-18283106	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs539624013	chr17:18283196-18283197	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs553576506	chr17:18283245-18283246	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs573447407	chr17:18283257-18283258	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs148170093	chr17:18283272-18283273	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs370258339	chr17:18283297-18283298	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs183792614	chr17:18283315-18283316	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs555293116	chr17:18283332-18283333	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs575255420	chr17:18283341-18283342	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs549262417	chr17:18283350-18283351	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs72840555	chr17:18283359-18283360	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs544262539	chr17:18283362-18283363	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs564221574	chr17:18283409-18283410	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs541925894	chr17:18283423-18283424	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs140918318	chr17:18283528-18283529	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs368406886	chr17:18283550-18283551	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs528422212	chr17:18283583-18283584	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs207476324	chr17:18283587-18283588	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs113444224	chr17:18283594-18283595	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs617624	chr17:18283627-18283628	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs529130716	chr17:18283642-18283643	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:163)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Autism	22543975	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Sezary syndrome	18413736	CNVD
Medulloblastoma	16783165	CNVD
Recurrent pregnancy loss	19789632	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:101 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:18267200-18288200	Weak transcription	Right Atrium	heart
2	chr17:18280400-18284200	Enhancers	Stomach Mucosa	stomach
3	chr17:18280600-18283200	Enhancers	Placenta Amnion	Placenta Amnion
4	chr17:18280600-18283800	Enhancers	Placenta	Placenta
5	chr17:18281400-18282600	Weak transcription	Rectal Mucosa Donor 29	rectum
6	chr17:18281400-18282600	Weak transcription	Rectal Mucosa Donor 31	rectum
7	chr17:18281400-18283000	Weak transcription	Fetal Thymus	thymus
8	chr17:18281400-18286400	Weak transcription	Gastric	stomach
9	chr17:18281600-18282600	Weak transcription	Colonic Mucosa	Colon
10	chr17:18281600-18282600	Weak transcription	HMEC	breast
11	chr17:18281600-18282600	Weak transcription	NHEK	skin
12	chr17:18281600-18283600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr17:18281600-18283800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr17:18281800-18282600	Weak transcription	Esophagus	oesophagus
15	chr17:18281800-18282800	Active TSS	Hela-S3	cervix
16	chr17:18281800-18283400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr17:18281800-18283600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr17:18282000-18282200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr17:18282200-18282400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr17:18282400-18283200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr17:18282600-18282800	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr17:18282600-18282800	Enhancers	Duodenum Mucosa	Duodenum
23	chr17:18282600-18282800	Enhancers	Rectal Mucosa Donor 29	rectum
24	chr17:18282600-18282800	Enhancers	HMEC	breast
25	chr17:18282600-18283000	Enhancers	Colonic Mucosa	Colon
26	chr17:18282600-18283000	Enhancers	NHEK	skin
27	chr17:18282600-18283800	Enhancers	Esophagus	oesophagus
28	chr17:18282800-18283000	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
29	chr17:18282800-18283000	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr17:18282800-18283000	Flanking Active TSS	Hela-S3	cervix
31	chr17:18282800-18283000	Bivalent Enhancer	HMEC	breast
32	chr17:18283000-18283200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr17:18283000-18283800	Enhancers	Rectal Mucosa Donor 29	rectum
34	chr17:18283000-18283800	Bivalent Enhancer	NHEK	skin
35	chr17:18283000-18288200	Enhancers	Fetal Thymus	thymus
36	chr17:18283200-18283800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr17:18283400-18283600	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr17:18283400-18283800	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr17:18283400-18287000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr17:18283600-18283800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
41	chr17:18283600-18284000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr17:18283600-18284000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
43	chr17:18283600-18284000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
44	chr17:18283600-18284000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
45	chr17:18283800-18284000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr17:18283800-18284000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr17:18283800-18284000	Bivalent Enhancer	Placenta	Placenta
48	chr17:18283800-18284200	Weak transcription	Esophagus	oesophagus
49	chr17:18283800-18284800	Weak transcription	Rectal Mucosa Donor 29	rectum
50	chr17:18283800-18286200	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links